← Back to Search

Cognitive-behavioral skills building intervention

Mental Health Resiliency Intervention for Suicide Prevention in Nurses

N/A
Recruiting
Research Sponsored by Ohio State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (timepoint 0), 8 weeks after baseline (timepoint 1), 3 months after screening (timepoint 2), 6 months after screening (timepoint 3), 12 months after screening (timepoint 4)
Awards & highlights
No Placebo-Only Group

Summary

This trial will test an intervention to prevent nurse suicide. Nurses will be recruited nationally and tested with a screening & skills building program.

Who is the study for?
This trial is for registered nurses who are at moderate to high risk of suicide, as identified by the HEAR-specific interactive screening program. Nurses must self-identify as such and be recognized nationally through the American Nurses Association.
What is being tested?
The study is testing two approaches: one group will use the HEAR program alone, which screens and refers clinicians for treatment anonymously online; another group will combine HEAR with MINDBODYSTRONG©, a cognitive-behavioral intervention with eight sessions designed to reduce depression and suicidal thoughts.
What are the potential side effects?
Since this trial involves psychological interventions rather than medications, traditional side effects are not expected. However, participants may experience emotional discomfort or distress while discussing sensitive topics during sessions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (timepoint 0), 8 weeks after baseline (timepoint 1), 3 months after screening (timepoint 2), 6 months after screening (timepoint 3), 12 months after screening (timepoint 4)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (timepoint 0), 8 weeks after baseline (timepoint 1), 3 months after screening (timepoint 2), 6 months after screening (timepoint 3), 12 months after screening (timepoint 4) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in is being assessed for an increase or decrease in self-reported depressive symptoms
Suicide
Secondary study objectives
Change in being assessed for an increase or decrease in self-reported anxiety symptoms
Change is being assessed for an increase or decrease in self-reported burnout level
Change is being assessed for an increase or decrease in self-reported healthy lifestyle behaviors
+5 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: mISPActive Control1 Intervention
Participants who are identified as having moderate to high risk of suicide, as identified by suicide risk on the ISP, will be contacted by a mental health counselor who will engage them through the mISP encrypted interface online. The mental health counselor will offer counseling online through encryption or on the phone. Where indicated, the mental health counselor will provide the crisis hotline, and encourage participants to use their insurance provider and/or Employee Assistance Program to obtain treatment. The mental health counselor will offer to help with referrals and will bridge high-risk participants into treatment. Participants who are not identified as having moderate to high risk of suicide will be thanked for their time.
Group II: mISP plus MINDSTRONGActive Control1 Intervention
Participants identified as having a moderate to high risk of suicide based on ISP screening will then be randomized. Participants randomized to the MINDBODYSTRONG© program (intervention) will receive the 8-session online interactive program. Reminders will be sent weekly to complete the next MINDBODYSTRONG© session and a MINDBODYSTRONG© trained coach will check in with participants by phone at baseline, weeks 3 and 5 of the on-line program to reinforce key program concepts and assess whether participants are completing the weekly skills building activities. Nurses assigned to the control group will only receive the mISP alone (aforementioned) and will be contacted for follow-up surveys.

Find a Location

Who is running the clinical trial?

Ohio State UniversityLead Sponsor
866 Previous Clinical Trials
649,957 Total Patients Enrolled
American Foundation for Suicide PreventionOTHER
34 Previous Clinical Trials
4,642 Total Patients Enrolled
University of San DiegoOTHER
4 Previous Clinical Trials
5,739 Total Patients Enrolled

Media Library

MINDBODYSTRONG™ (Cognitive-behavioral skills building intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05582343 — N/A
Burnout Research Study Groups: mISP, mISP plus MINDSTRONG
Burnout Clinical Trial 2023: MINDBODYSTRONG™ Highlights & Side Effects. Trial Name: NCT05582343 — N/A
MINDBODYSTRONG™ (Cognitive-behavioral skills building intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05582343 — N/A
~1972 spots leftby Oct 2025